(Q85670159)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221757%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

Key role of the kidney in the regulation of fibroblast growth factor 23 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221757%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221757%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

2

Eva Gravesen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221757%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

5

Ewa Lewin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221757%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Maria L Mace

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221757%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Jacob Hofman-Bang

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221757%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

language of work or name

English

0 references

publication date

29 July 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221757%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221757%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221757%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221757%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

1304-1313

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26221757%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.2015.231

20 February 2020

exact match

0 references

cites work

Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism

1 reference

12 December 2020

Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

1 reference

12 December 2020

Circulating FGF23 levels in response to acute changes in plasma Ca(2+)

1 reference

12 December 2020

Calcium deficiency reduces circulating levels of FGF23.

1 reference

12 December 2020

Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active

1 reference

12 December 2020

Insights from genetic disorders of phosphate homeostasis

1 reference

12 December 2020

Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism

1 reference

12 December 2020

Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo

1 reference

12 December 2020

Involvement of alpha-klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism.

1 reference

12 December 2020

Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia

1 reference

12 December 2020

Effects of dietary phosphate and calcium intake on fibroblast growth factor-23

1 reference

12 December 2020

Bone as a source of FGF23: regulation by phosphate?

1 reference

12 December 2020

Rapid recovery of plasma ionized calcium after acute induction of hypocalcaemia in parathyroidectomized and nephrectomized rats

1 reference

12 December 2020

Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo

1 reference

12 December 2020

1,25-dihydroxyvitamin D(3) regulation of fibroblast growth factor-23 expression in bone cells: evidence for primary and secondary mechanisms modulated by leptin and interleukin-6

1 reference

12 December 2020

Increased parathyroid expression of klotho in uremic rats

1 reference

12 December 2020

FGF-23 levels in patients with AKI and risk of adverse outcomes.

1 reference

12 December 2020

Persistent alpha-Klotho (a-Kl) expression in the parathyroid glands of patients with secondary hyperparathyroidism

1 reference

12 December 2020

Fibroblast growth factor 23 and Inflammation in CKD

1 reference

12 December 2020

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.

1 reference

12 December 2020

Role of the vitamin D receptor in FGF23 action on phosphate metabolism

1 reference

12 December 2020

Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism

1 reference

12 December 2020

Fibroblast growth factor 23 production in bone is directly regulated by 1α,25-dihydroxyvitamin D, but not PTH

1 reference

12 December 2020

Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women

1 reference

12 December 2020

Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men

1 reference

12 December 2020

Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease

1 reference

12 December 2020

The human response to acute enteral and parenteral phosphate loads

1 reference

12 December 2020

Regulation and function of the FGF23/klotho endocrine pathways

1 reference

12 December 2020

Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

1 reference

12 December 2020

FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment

1 reference

12 December 2020

The parathyroid is a target organ for FGF23 in rats

1 reference

12 December 2020

FGF23 promotes renal calcium reabsorption through the TRPV5 channel

1 reference

12 December 2020

Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling.

1 reference

12 December 2020

Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism.

1 reference

12 December 2020

1,25(OH)2D3 only affects long-term levels of plasma Ca2+ but not the rapid minute-to-minute plasma Ca2+ homeostasis in the rat

1 reference

12 December 2020

FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis

1 reference

12 December 2020

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

1 reference

12 December 2020

Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis

1 reference

12 December 2020

FGF-23 and PTH levels in patients with acute kidney injury: A cross-sectional case series study

1 reference

12 December 2020

Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans

1 reference

12 December 2020

Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC.

1 reference

12 December 2020

Plasma FGF23 levels increase rapidly after acute kidney injury.

1 reference

12 December 2020

Fibroblast growth factor 23 reduces expression of type IIa Na+/Pi co-transporter by signaling through a receptor functionally distinct from the known FGFRs in opossum kidney cells.

1 reference

12 December 2020

PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop

1 reference

12 December 2020

The secretory response of parathyroid hormone to acute hypocalcemia in vivo is independent of parathyroid glandular sodium/potassium-ATPase activity

1 reference

12 December 2020

1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism.

1 reference

12 December 2020

1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport

1 reference

12 December 2020

Determination of the elimination half-life of fibroblast growth factor-23

1 reference

12 December 2020

Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations

1 reference

12 December 2020

A potential kidney-bone axis involved in the rapid minute-to-minute regulation of plasma Ca2+

1 reference

12 December 2020

Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease

1 reference

12 December 2020

Interactions between calcium and phosphorus in the regulation of the production of fibroblast growth factor 23 in vivo

1 reference

12 December 2020

Intravenous phosphate loading increases fibroblast growth factor 23 in uremic rats

1 reference

12 December 2020

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

1 reference

12 December 2020

Dietary phosphate restriction suppresses phosphaturia but does not prevent FGF23 elevation in a mouse model of chronic kidney disease

1 reference

12 December 2020

Structural and biochemical properties of fibroblast growth factor 23.

1 reference

12 December 2020

Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism

1 reference

12 December 2020

Role of calcitonin in the rapid minute-to-minute regulation of plasma Ca2+ homeostasis in the rat.

1 reference

12 December 2020

Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro

1 reference

12 December 2020

Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells

1 reference

12 December 2020

Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism

1 reference

12 December 2020

Post-translational modification of Fibroblast Growth Factor 23.

1 reference

12 December 2020

Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease

1 reference

12 December 2020

Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease.

1 reference

12 December 2020

Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice

1 reference

12 December 2020

Renal expression of FGF23 in progressive renal disease of diabetes and the effect of ACE inhibitor

1 reference

12 December 2020

Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo.

1 reference

12 December 2020

Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice.

1 reference

12 December 2020

A model of reversible uremia employing isogenic kidney transplantation in the rat. Reversibility of secondary hyperparathyroidism

1 reference

12 December 2020

Parathyroid hormone is not a key hormone in the rapid minute-to-minute regulation of plasma Ca2+ homeostasis in rats

1 reference

12 December 2020

FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone

1 reference

12 December 2020

Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease

1 reference

12 December 2020

The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84)

1 reference

12 December 2020

Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription

1 reference

12 December 2020

FGF23 fails to inhibit uremic parathyroid glands

1 reference

12 December 2020

Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo.

1 reference

12 December 2020

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1 reference

12 December 2020

FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa.

1 reference

12 December 2020

FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1.

1 reference

12 December 2020

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

1 reference

12 December 2020

Antibody-mediated activation of FGFR1 induces FGF23 production and hypophosphatemia

1 reference

12 December 2020

Mineralized tissue cells are a principal source of FGF23.

1 reference

12 December 2020

Rate-dependency of calcitonin secretion in response to increased plasma Ca2+.

1 reference

12 December 2020

Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men.

1 reference

12 December 2020

FGF23-parathyroid interaction: implications in chronic kidney disease

1 reference

12 December 2020

Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD.

1 reference

12 December 2020

Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation

1 reference

12 December 2020